Immunome Issues Inducement Equity Grants
BOTHELL, Wash., Feb. 6, 2026 — Immunome, Inc., a clinical-stage biotechnology company developing targeted oncology therapeutics, announced that its...
Capital for New Therapy
Veradermics Closes Full IPO Share Option Exercise
NEW HAVEN, Conn., Feb. 5, 2026 — Veradermics, Incorporated, a late clinical-stage biopharmaceutical company focused on dermatology therapeutics, announced...
SlateVC Closes €132M First Close to Back Climate Tech Growth in Europe
PARIS, France, February 4, 2026 — Slate Venture Capital (SlateVC), a Paris-based growth-focused investment firm dedicated to advancing climate...
Santé Ventures Raises $330M to Fund Early-Stage Life Sciences Innovation
AUSTIN, Texas, Feb. 2, 2026 — Early-stage investor Santé Ventures announced the successful close of its fifth and largest...
LifeArc Ventures Scales Global VC Portfolio in Life Sciences
London, United Kingdom | January 29, 2026 — LifeArc Ventures, the venture capital arm of medical research organization LifeArc,...
TRexBio Secures $50M to Advance Precision Treg Therapies
SOUTH SAN FRANCISCO, CALIFORNIA | January 27, 2026 — TRexBio, Inc., a clinical-stage biotechnology company focused on precision immunoregulatory...
Moolec Secures Nasdaq Panel Support to Regain Listing Compliance
GEORGE TOWN, CAYMAN ISLANDS | January 26, 2026 — Moolec Science S.A. announced that Nasdaq Staff has issued a...
Phio Pharmaceuticals Highlights siRNA Oncology Program at DealFlow
KING OF PRUSSIA, PENNSYLVANIA | January 26, 2026 — Phio Pharmaceuticals has announced its participation in the Third Annual...
Think Bioscience Secures $55M Series A to Drug “Undruggable” Targets
Boulder, Colorado, January 20, 2026 — Think Bioscience, a privately held biotechnology company focused on unlocking historically “undruggable” drug...
Cardiol Raises $13.5M to Advance Late-Stage Heart Drug Trials
Toronto, Ontario, January 16, 2026 — Cardiol Therapeutics announced a bought deal private placement financing for gross proceeds of...